1. Home
  2. IPDN vs EVGN Comparison

IPDN vs EVGN Comparison

Compare IPDN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IPDN

Professional Diversity Network Inc.

HOLD

Current Price

$0.78

Market Cap

9.5M

Sector

Technology

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.81

Market Cap

9.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPDN
EVGN
Founded
2003
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Agricultural Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
9.6M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
IPDN
EVGN
Price
$0.78
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
73.8K
44.1K
Earning Date
05-15-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,054,219.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.72
52 Week High
$12.39
$2.42

Technical Indicators

Market Signals
Indicator
IPDN
EVGN
Relative Strength Index (RSI) 36.53 40.06
Support Level N/A $0.73
Resistance Level $1.02 $1.23
Average True Range (ATR) 0.08 0.06
MACD -0.01 -0.00
Stochastic Oscillator 28.72 10.66

Price Performance

Historical Comparison
IPDN
EVGN

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: